A “PSA Pyramid” for Men with Initial Prostate-specific Antigen ≤3 ng/ml: A Plea for Individualized Prostate Cancer Screening

A “PSA Pyramid” for Men with Initial Prostate-specific Antigen ≤3 ng/ml: A Plea for Individualized Prostate Cancer Screening

Abstract Background In daily routine business, various prostate-specific antigen (PSA) retest strategies are being promoted. Objective To investigate rescreening intervals according to baseline PSA

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European urology 2015-10, Vol.68 (4), p.591-597
Hauptverfasser: Randazzo, Marco, Beatrice, Josef, Huber, Andreas, Grobholz, Rainer, Manka, Lukas, Chun, Felix K, Recker, Franz, Kwiatkowski, Maciej
Format: Artikel
Sprache:eng
Schlagworte:
Aged
Biopsy
Decision Support Techniques
Disease-Free Survival
Early detection
Early Detection of Cancer
Humans
Kallikreins - blood
Kaplan-Meier Estimate
Male
Middle Aged
Multivariate Analysis
Neoplasm Grading
Predictive Value of Tests
Proportional Hazards Models
Prospective Studies
Prostate cancer
Prostate-Specific Antigen - blood
Prostatic Neoplasms - blood
Prostatic Neoplasms - pathology
Risk Assessment
Risk Factors
Screening
Screening interval
Survival
Switzerland
Time Factors
Up-Regulation
Urology
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract Background In daily routine business, various prostate-specific antigen (PSA) retest strategies are being promoted. Objective To investigate rescreening intervals according to baseline PSA
ISSN:0302-2838
1873-7560
DOI:10.1016/j.eururo.2014.04.005